Credit: Shutterstock. SP-103 is a next generation triple strength formulation of ZTlido (lidocaine topical system) 1.8%. The Food and Drug Administration (FDA) has granted Fast Track designation to SP ...

The 5% lidocaine patch received approval from the US Food and Drug Administration in 1999 for one specific indication — relief of pain in PHN — and studies have demonstrated its safety and efficacy in ...

CHADDS FORD, Pa., March 31, 2005 – Today at the 24th Annual Scientific Meeting of the American Pain Society, Endo Pharmaceuticals Inc. released new clinical trial data which found patients receiving ...

Aveva Drug Delivery Systems has received permission from the Food and Drug Administration for its generic lidocaine 1.8% patch, a non-opioid topical treatment for post-herpetic neuralgia. The generic ...

Private insurers offer Medicare Advantage (Part C) plans, which may include supplemental benefits for over-the-counter (OTC) drugs or pharmacy items. You may be able to use your plan’s ...

The methods used in this study are similar to those previously published by Gammaitoni and Davis. [12] The protocol and informed consent forms for this study were reviewed and approved by the ...

Scilex Holding Company announced the publication of a study in Pain Medicine News revealing that patients treated with ZTlido® (lidocaine topical system 1.8%) showed a greater reduction in opioid use ...

opioids In a meta-analysis, researchers evaluated whether a lidocaine patch is beneficial for postoperative pain as an option for multimodal analgesia. The use of lidocaine patches for postoperative ...

If you’ve ever dealt with back pain, you know how debilitating it can be. Back pain makes everyday experiences like sitting at your desk, performing on stage, or getting in a midday workout seem ...

Mylan Pharmaceuticals (Nasdaq: MYL) has won a potential $121.5 million contract from the Defense Logistics Agency to provide lidocaine 5 percent patch, a medicine designed for the treatment of ...

The pharmacokinetics, safety, and tolerability of four topical lidocaine patches 5% continuously applied for 72 hours and changed every 12 or 24 hours were examined. In this randomized, prospective, ...